Characteristics and response cutoff of Octreotide Suppression Test in Thyrotropin (TSH)-secreting pituitary adenomas.
Sign Up to like & getrecommendations! Published in 2023 at "Clinical endocrinology"
DOI: 10.1111/cen.14921
Abstract: CONTEXT Somatostatin analogs are recommended for preoperative therapy in Thyrotropin secreting pituitary adenomas (TSHomas). Octreotide suppression test (OST) was designed to differentiate TSHomas with Resistance to Thyroid Hormones, while its ability to test sensitivity of… read more here.
Keywords: suppression test; timepoint; octreotide suppression; suppression ... See more keywords